BYDUREON
2MG INJ PLQ SUS PRO 12(3X4)+3J
Announcement of launch, break or close-out of marketing of a medicinal product:
https://prehledy.sukl.cz/mr.html?filtr=0210104All reports are available in the Overview.
2MG INJ PLQ SUS PRO 12(3X4)+3J
All reports are available in the Overview.
2010 © SÚKL. Šrobárova 48, 100 41 Praha 10, +420 272 185 111, posta@sukl
cz.
